Hypertrophic scars remain one of the most persistent challenges in wound healing, often resulting in excessive fibrosis, disfigurement, and long-term functional impairment. Researchers now report a ...

CollPlant is now moving towards clinical trials and scaling and optimizing its manufacturing to ensure readiness for the upcoming clinical trials REHOVOT, Israel, Sept. 30, 2025 /PRNewswire/ -- ...

Please provide your email address to receive an email when new articles are posted on . Two calcium hydroxyapatite-based derma fillers were compared. Filler suspended in carboxymethylcellulose induced ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies ...

CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent: Rehovot, Israel Saturday, February 28, 2026, 14:00 Hrs [IST] CollPlant Biotechnologies, ...

Michael Freeman is the founder of The Skin Centre, a private dermatology practice which also offers dermal fillers. Fillers are now one of the most common non-surgical cosmetic procedures. Adding ...

Future Market Insights (FMI) projects the dermal fillers market to grow from USD 6.8 billion in 2026 to USD 9.9 billion by 2036, expanding at a 3.2% CAGR. Market momentum is being shaped by rising ...